Immune Cell Interactions in Atherosclerosis

动脉粥样硬化中的免疫细胞相互作用

基本信息

  • 批准号:
    10334090
  • 负责人:
  • 金额:
    $ 28.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2022-06-02
  • 项目状态:
    已结题

项目摘要

Overall Abstract Our PPG will test the hypothesis that the lipid and protein components of lipoproteins trigger innate and adaptive immune responses that control human atherosclerosis. We will study the immune cell cross-talk that occurs during human atherosclerosis progression. Immunity plays an important role in coronary artery disease (CAD), as recent clinical trials have clearly demonstrated. However, these trials also taught us that systemic treatments of the immune system, by their very nature, impair host defense. Thus, it is imperative to find new, more specific interventions that modulate immune cell function in atherosclerosis, yet spare host defense. We will study immune cells and plasma from human subjects from 3 well-characterized clinical cohorts, 1-our existing CAVA cohort (Coronary Assessment at Virginia), where subjects are enrolled from the UVA cardiac catheterization laboratory that undergo quantitative coronary analysis for disease quantification; 2- Computerized Tomography (CT)-CAVA cohort, where subjects undergoing noninvasive CT angiography for cardiovascular disease assessment in years 1 and 2 of the PPG renewal (baseline measures) will be followed up at 3 years to allow for determination of coronary plaque progression and changes in markers of plaque vulnerability, and 3- The Multi-Ethnic Study of Atherosclerosis (MESA), a large NHLBI-sponsored longitudinal cohort that has been ongoing since 2000. In this synergistic program, Project 1 CD9+ Monocyte and Macrophage Immune Functions in Atherosclerosis has identified new monocyte subsets expressing the tetraspanin CD9, and will study how CD9 impacts metabolism and immune modulation of monocytes and macrophages in CAD. Project 2 Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis will study how specialized lipid raft signaling drives transcriptional and metabolic reprogramming in macrophages. Project 3 Regulation of Atheroprotective IgM-producing B cells in Murine and Human Atherosclerosis will study how CD24 and CCR6 on newly identified human B-1 cell subsets modulate atheroprotective IgM production. Project 4 ApoB-Specific CD4 and CD8 T cells Exacerbate Atherosclerosis will identify and study immunodominant human apolipoprotein B (apoB) epitopes to investigate how these activate CD4 and CD8 T cell using mouse models to address mechanisms. An important synergistic aspect to our PPG is that it is highly interactive, in that B cells, T cells, monocytes and macrophages communicate with each other in the artery wall and in lymphoid tissues. Unique aspects of our program are the focus on studying human immune cells, the link to biospecimens and clinical data from 3 complementary cardiovascular cohorts, the use of unbiased high dimensional protein and RNA-sequencing at the single cell level for all human immune cells from the same human subjects, and our ability to link all of our group’s discoveries with extensive clinical data on each subject. The human studies are complemented by murine mechanistic models where applicable. The end goal of our studies is to identify safe new therapeutic strategies targeting immune cell function to limit CAD.
总体摘要 我们的PPG将检验脂蛋白的脂质和蛋白质成分触发先天性和 控制人类动脉粥样硬化的适应性免疫反应。我们将研究免疫细胞的相互作用, 发生在人类动脉粥样硬化进展过程中。免疫在冠状动脉疾病中起重要作用 (CAD)最近的临床试验已经清楚地证明。然而,这些试验也告诉我们, 免疫系统的治疗,就其本质而言,损害了宿主的防御。因此,必须找到新的, 更具体的干预措施,调节免疫细胞功能的动脉粥样硬化,但备用主机防御。我们 将研究来自3个充分表征的临床队列(1-我们的 现有CAVA队列(弗吉尼亚州冠状动脉评估),其中受试者从UVA心脏 进行定量冠状动脉分析以进行疾病量化的导管插入实验室; 2- 计算机断层扫描(CT)-CAVA队列,受试者接受无创CT血管造影, 将随访PPG更新第1年和第2年的心血管疾病评估(基线测量) 最多3年,以确定冠状动脉斑块进展和斑块标志物的变化 脆弱性,和3-动脉粥样硬化的多种族研究(梅萨),一个大型的NHLBI赞助 自2000年以来一直在进行的纵向队列研究。在这个协同项目中,项目1 CD 9+单核细胞 和巨噬细胞免疫功能在动脉粥样硬化已经确定了新的单核细胞亚群表达 四跨膜蛋白CD 9,并将研究CD 9如何影响单核细胞的代谢和免疫调节, CAD中的巨噬细胞。项目2动脉粥样硬化中炎症性巨噬细胞的胆固醇调节 研究专门的脂筏信号如何驱动巨噬细胞的转录和代谢重编程。 项目3研究小鼠和人类动脉粥样硬化中产生抗动脉粥样硬化IgM的B细胞的调节 新鉴定的人B-1细胞亚群上的CD 24和CCR 6如何调节抗动脉粥样硬化IgM的产生。 项目4 ApoB特异性CD 4和CD 8 T细胞急性动脉粥样硬化将识别和研究 免疫显性人载脂蛋白B(apoB)表位,以研究这些表位如何激活CD 4和CD 8 T 细胞使用小鼠模型来解决机制。我们PPG的一个重要协同方面是, 相互作用,在B细胞中,T细胞、单核细胞和巨噬细胞在动脉壁中相互沟通 和淋巴组织中。我们计划的独特之处是专注于研究人类免疫细胞, 链接到来自3个互补心血管队列的生物样本和临床数据,使用无偏高 在单细胞水平上对来自相同细胞的所有人免疫细胞进行三维蛋白质和RNA测序, 人类受试者,以及我们将我们小组的所有发现与每个人的广泛临床数据联系起来的能力。 话题吧在适用的情况下,通过鼠机制模型补充人体研究。年底 我们研究的目的是确定安全的新的治疗策略,靶向免疫细胞功能,以限制CAD。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Catherine C Hedrick其他文献

Stressing out stem cells: linking stress and hematopoiesis in cardiovascular disease
应激干细胞:将心血管疾病中的应激与造血作用联系起来
  • DOI:
    10.1038/nm.3631
  • 发表时间:
    2014-07-07
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Richard N Hanna;Catherine C Hedrick
  • 通讯作者:
    Catherine C Hedrick

Catherine C Hedrick的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Catherine C Hedrick', 18)}}的其他基金

Neutrophil Development During Inflammation and Atherosclerosis
炎症和动脉粥样硬化期间中性粒细胞的发育
  • 批准号:
    10651786
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
Neutrophil Development During Inflammation and Atherosclerosis
炎症和动脉粥样硬化期间中性粒细胞的发育
  • 批准号:
    10270897
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
Neutrophil Development During Inflammation and Atherosclerosis
炎症和动脉粥样硬化期间中性粒细胞的发育
  • 批准号:
    10470240
  • 财政年份:
    2021
  • 资助金额:
    $ 28.97万
  • 项目类别:
2019 Atherosclerosis Gordon Research Conference and Gordon Research Seminar
2019年动脉粥样硬化戈登研究大会暨戈登研究研讨会
  • 批准号:
    9759445
  • 财政年份:
    2019
  • 资助金额:
    $ 28.97万
  • 项目类别:
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
非经典单核细胞在实体癌免疫治疗中的保护作用
  • 批准号:
    9899213
  • 财政年份:
    2018
  • 资助金额:
    $ 28.97万
  • 项目类别:
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
非经典单核细胞在实体癌免疫治疗中的保护作用
  • 批准号:
    9471276
  • 财政年份:
    2018
  • 资助金额:
    $ 28.97万
  • 项目类别:
Project 1: Regulation of CD9+ Monocyte & Macrophage Immune Functions in Atherosclerosis
项目1:CD9单核细胞的调控
  • 批准号:
    10334094
  • 财政年份:
    2017
  • 资助金额:
    $ 28.97万
  • 项目类别:
Immune Cell Interactions in Atherosclerosis
动脉粥样硬化中的免疫细胞相互作用
  • 批准号:
    10623039
  • 财政年份:
    2017
  • 资助金额:
    $ 28.97万
  • 项目类别:
Core A: Admin Core
核心 A:管理核心
  • 批准号:
    10334091
  • 财政年份:
    2017
  • 资助金额:
    $ 28.97万
  • 项目类别:
Monocyte Subsets & Immunity in Mouse and Human Atherosclerosis
单核细胞亚群
  • 批准号:
    10188605
  • 财政年份:
    2017
  • 资助金额:
    $ 28.97万
  • 项目类别:

相似海外基金

ImproviNg rEnal outcomes following coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a pragmatic, adaptive, patient-oriented randomized controlled trial
改善冠状动脉造影和/或经皮冠状动脉介入治疗后的肾脏结局:一项务实、适应性、以患者为导向的随机对照试验
  • 批准号:
    478732
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Operating Grants
SBIR Phase II: Novel size-changing, gadolinium-free contrast agent for magnetic resonance angiography
SBIR II 期:用于磁共振血管造影的新型尺寸变化、无钆造影剂
  • 批准号:
    2322379
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Cooperative Agreement
Neonatal Optical Coherence Tomography Angiography to Assess the Effects of Postnatal Exposures on Retinal Development and Predict Neurodevelopmental Outcomes
新生儿光学相干断层扫描血管造影评估产后暴露对视网膜发育的影响并预测神经发育结果
  • 批准号:
    10588086
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
Motion-Resistant Background Subtraction Angiography with Deep Learning: Real-Time, Edge Hardware Implementation and Product Development
具有深度学习的抗运动背景减影血管造影:实时、边缘硬件实施和产品开发
  • 批准号:
    10602275
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
Highly Accelerated Magnetic Resonance Angiography using Deep Learning
使用深度学习的高加速磁共振血管造影
  • 批准号:
    2886357
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Studentship
Development of a method to simultaneously obtain cerebral blood flow information and progression of cerebral white matter lesions using head MR angiography.
开发一种使用头部磁共振血管造影同时获取脑血流信息和脑白质病变进展的方法。
  • 批准号:
    23K14839
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of a new diagnostic method for coronary artery disease using automated image analysis with postmortem coronary angiography CT
使用死后冠状动脉造影 CT 自动图像分析开发冠状动脉疾病的新诊断方法
  • 批准号:
    23K19795
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Novel ultrahigh speed swept source OCT angiography methods in diabetic retinopathy
糖尿病视网膜病变的新型超高速扫源 OCT 血管造影方法
  • 批准号:
    10656644
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
Automated Machine Learning-Based Brain Artery Segmentation, Anatomical Prior Labeling, and Feature Extraction on MR Angiography
基于自动机器学习的脑动脉分割、解剖先验标记和 MR 血管造影特征提取
  • 批准号:
    10759721
  • 财政年份:
    2023
  • 资助金额:
    $ 28.97万
  • 项目类别:
SCH: A physics-informed machine learning approach to dynamic blood flow analysis from static subtraction computed tomographic angiography imaging
SCH:一种基于物理的机器学习方法,用于从静态减影计算机断层血管造影成像中进行动态血流分析
  • 批准号:
    2205265
  • 财政年份:
    2022
  • 资助金额:
    $ 28.97万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了